Study Reveals Histopathologic Findings in the Muscle and Nerve in Patients With Severe COVID-19
Researchers analyzed the autopsies of patients who died from COVID-19 to understand the pathophysiology of COVID-19-related myopathy.
Emerging Diseases
Baricitinib Does Not Cut COVID-19 Progression in Hospitalized Adults
But placebo-controlled trial shows lower all-cause mortality at 28 days and 60 days in patients receiving baricitinib plus standard of care.
Current Guidelines May Lead to Antibiotic Overuse for SARS-CoV-2 Pneumonia
Bacterial superinfection at time of intubation occurred in <25 percent of patients; reduced antibiotic use seen with bronchoalveolar lavage-based management versus current guidelines.
COVID-19 Cases Rise Sharply Among Children as School Year Starts
While cases declined in early summer, they have ‘increased exponentially’ recently, with more than a fivefold increase in the past month.
Healthy, Plant-Based Diet Tied to Lower COVID-19 Risk
Association seems to be particularly pronounced among individuals living in areas with higher socioeconomic deprivation.
Does Anakinra Have a Role in the Treatment of Severe COVID-19?
Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.
Outcomes Similar With CPAP, Oxygen Therapy for Severe COVID-19
Clinical outcomes compared in retrospective cohort study of COVID-19 patients deemed unlikely to benefit from invasive mechanical ventilation.
Americans’ COVID-19 Medical Bills Are Set to Rise
Research shows that the average COVID-19 hospitalization costs about $40,000.
New ‘Mu’ Coronavirus Variant Being Watched Closely: Fauci
Variant has not taken extensive hold in the United States at this point, but NIAID is taking it ‘very seriously’.
Teachers Not at Increased Risk for Hospital Admission for COVID-19
Risk for hospital admission, severe COVID-19 not increased when schools in Scotland opened in autumn 2020 and in summer 2021.
- Loading...
Loading...
Next post in COVID19
Loading... 
Loading...